Application 207534
- Type
- NDA
- Sponsor
- ADAMIS PHARMS CORP
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SYMJEPI | EPINEPHRINE | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 0.3MG/0.3ML (0.3MG/0.3ML) | Yes | Yes |
| 002 | SYMJEPI | EPINEPHRINE | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 0.15MG/0.3ML (0.15MG/0.3ML) | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N207534-001 | SYMJEPI | EPINEPHRINE | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | |
| N207534-002 | SYMJEPI | EPINEPHRINE | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 |
| N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD | 2018-09-27 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2018-09-27 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N207534-001 | SYMJEPI | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2017-06-15 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N207534-002 | SYMJEPI | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION / INTRAMUSCULAR, SUBCUTANEOUS | RLD, RS | 2018-09-27 | 5d02ea3f76ae… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2023-12-20 04:57 UTC | 2023-12 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 3f0d92c62455… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | cb3db0bc1861… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N207534-001 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N207534-002 | 11141540 | 2036-10-20 | U-3379 | Drug product | 2022-06-16 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| epinephrine | EPINEPHRINE | GLENMARK PHARMACEUTICALS INC., USA | cc4ebb51-6020-4339-a36a-ec2380b7d28e | 2026-11-03 | Warnings, Adverse reactions | EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | Henry Schein, Inc. | 3b1ac82f-6920-4e40-a77e-598398679f2d | 2026-10-28 | Warnings, Adverse reactions | EPINEPHRINE |
| epinephrine | EPINEPHRINE | Gland Pharma Limited | 577f987e-d3af-4f49-ab44-5db9cbf46601 | 2026-10-27 | Warnings, Adverse reactions | EPINEPHRINE |
| epinephrine | EPINEPHRINE | Baxter Healthcare Corporation | 60efd409-3555-4182-a68d-1cd7bc0d1bfc | 2026-10-19 | Warnings, Adverse reactions | EPINEPHRINE |
| Epinephrine | EPINEPHRINE | Sportpharm LLC | a8e98483-9404-43bc-8800-b827c63c5134 | 2026-10-12 | Warnings, Adverse reactions | EPINEPHRINE |
| epinephrine | EPINEPHRINE | Gland Pharma Limited | 79ca73ca-d3c0-40af-9dec-e2f4ce669cda | 2026-09-23 | Warnings, Adverse reactions | EPINEPHRINE |
| Auvi-Q | EPINEPHRINE | Sportpharm LLC | 5f40988b-8365-4f7b-84d1-b88e053725cf | 2026-09-18 | Warnings, Adverse reactions | EPINEPHRINE |
| epinephrine | EPINEPHRINE | REMEDYREPACK INC. | bfc7ab3d-1e0e-4fd9-b6df-09603eb5808c | 2026-09-17 | Warnings, Adverse reactions | EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | REMEDYREPACK INC. | 55befbe4-c819-4367-bbe7-de5841786aac | 2026-09-03 | Warnings, Adverse reactions | EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | REMEDYREPACK INC. | 5ba14408-c8fb-4734-aad9-ee19696acac2 | 2026-08-28 | Warnings, Adverse reactions | EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 5725a519-3ad6-7e5e-e063-6394a90a111f | 2026-08-10 | Warnings, Adverse reactions | EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 5726eeca-db88-ba8e-e063-6294a90a927d | 2026-08-03 | Warnings, Adverse reactions | EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | Fresenius Kabi USA, LLC | a6afb9e8-1db9-480c-8d31-58c5c870ca49 | 2026-07-29 | Warnings, Adverse reactions | EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | Fresenius Kabi USA, LLC | 4f83895f-638c-4515-af03-7c41ae60a42e | 2026-07-15 | Warnings, Adverse reactions | EPINEPHRINE |
| Epinephrine | EPINEPHRINE | A-S Medication Solutions | 6e811e28-0199-4df7-a916-5940c632401d | 2026-07-13 | Warnings, Adverse reactions | EPINEPHRINE |
| EPINEPHRINE | EPINEPHRINE | CIVICA, INC. | 4a79ad00-405b-4454-a692-7f1daac4adec | 2026-07-10 | Warnings, Adverse reactions | EPINEPHRINE |
| Epinephrine | EPINEPHRINE | A-S Medication Solutions | 386519ba-7a44-4edd-9eb1-748419b7a71b | 2026-07-06 | Warnings, Adverse reactions | EPINEPHRINE |
| Adrenalin | EPINEPHRINE | Par Health USA, LLC | 3b7a4364-668d-4eb2-a20c-04adc35aabe4 | 2026-07-01 | Warnings, Adverse reactions | EPINEPHRINE |
| Epinephrine | EPINEPHRINE | REMEDYREPACK INC. | 0172280c-f7d6-4613-9dbd-f94d3ae5825a | 2026-06-08 | Warnings, Adverse reactions | EPINEPHRINE |
| Epinephrine | EPINEPHRINE | Hikma Pharmaceuticals USA Inc. | 1e8ebac1-5b32-47f9-a930-86a98a24dccc | 2026-05-05 | Warnings, Adverse reactions | EPINEPHRINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0781-3442 | SYMJEPI | Epinephrine | Sandoz Inc. | NDA | Current |
| 0781-3442 | SYMJEPI | Epinephrine | Sandoz Inc. | NDA | Current |
| 0781-3442 | SYMJEPI | Epinephrine | Sandoz Inc. | NDA | Current |
| 0781-3442 | SYMJEPI | Epinephrine | Sandoz Inc. | NDA | Current |
| 0781-3442 | SYMJEPI | Epinephrine | Sandoz Inc. | NDA | Current |
| 0781-3448 | SYMJEPI | Epinephrine | Sandoz Inc. | NDA | Current |
| 0781-3448 | SYMJEPI | Epinephrine | Sandoz Inc. | NDA | Current |
| 0781-3448 | SYMJEPI | Epinephrine | Sandoz Inc. | NDA | Current |
| 0781-3448 | SYMJEPI | Epinephrine | Sandoz Inc. | NDA | Current |
| 38739-200 | SYMJEPI | Epinephrine | Adamis Pharmaceuticals Corporation | NDA | Current |
| 78670-130 | Symjepi | epinephrine | USWM, LLC | NDA | Current |
| 78670-130 | Symjepi | epinephrine | USWM, LLC | NDA | Current |
| 78670-130 | Symjepi | epinephrine | USWM, LLC | NDA | Current |
| 78670-130 | Symjepi | epinephrine | USWM, LLC | NDA | Current |
| 78670-131 | Symjepi | epinephrine | USWM, LLC | NDA | Current |
| 78670-131 | Symjepi | epinephrine | USWM, LLC | NDA | Current |
| 78670-131 | Symjepi | epinephrine | USWM, LLC | NDA | Current |
| 78670-131 | Symjepi | epinephrine | USWM, LLC | NDA | Current |